ORAGENICS, INC. Operating Lease, Liability, Noncurrent
ORAGENICS, INC. (OGEN) had Operating Lease, Liability, Noncurrent of $65.75 thousand as of 2023-06-30, per its 10-Q filed 2023-08-11.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2024-03-29
- 2023-06-30: Operating Lease, Liability, Noncurrent $65.75K.
- 2023-03-31: Operating Lease, Liability, Noncurrent $104.46K.
- 2022-12-31: Operating Lease, Liability, Noncurrent $152.44K.
- 2022-09-30: Operating Lease, Liability, Noncurrent $204.59K.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2023-06-30 | $65.75K 10-Q · filed 2023-08-11 |
| 2023-03-31 | $104.46K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $152.44K 10-K · filed 2024-03-29 |
| 2022-09-30 | $204.59K 10-Q/A · filed 2023-04-14 |
| 2022-06-30 | $217.35K 10-Q/A · filed 2023-04-14 |
| 2022-03-31 | $253.93K 10-Q/A · filed 2023-04-14 |
| 2021-12-31 | $299.52K 10-K · filed 2023-04-17 |
| 2021-09-30 | $349.20K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $398.18K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $446.46K 10-Q · filed 2021-05-03 |
| 2020-12-31 | $493.79K 10-K/A · filed 2022-07-29 |
| 2020-09-30 | $539.38K 10-Q · filed 2020-11-10 |
| 2020-06-30 | $583.87K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $627.72K 10-Q · filed 2020-05-15 |
| 2019-12-31 | $670.69K 10-K · filed 2021-03-01 |
| 2019-09-30 | $586.17K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $616.16K 10-Q · filed 2019-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |